ctrl K

Price Alert

Aerovate Therapeutics Inc... (AVTE)

NASDAQ: AVTE · Real-Time Price · USD

2.68

0.00 (0.00%)

At close: Apr 28, 2025, 3:59 PM

Aerovate Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	33.75M	23.49M	22.4M	54.2M
Short-Term Investments	44.87M	98.95M	106.82M	113.18M
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	2.28M	2.56M	302K
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	845K	250K	295K	240K
Total Current Assets	80.12M	124.23M	131.5M	174.33M
Property-Plant & Equipment	215K	902K	1.25M	728K
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	215K	3.19M	3.81M	1.03M
Total Assets	80.33M	127.42M	135.3M	175.36M
Account Payables	224K	2.4M	2.58M	1.21M
Deferred Revenue	n/a	n/a	n/a	1.01M
Short-Term Debt	n/a	n/a	385K	192K
Other Current Liabilities	319K	1.09M	2.75M	168K
Total Current Liabilities	3.83M	17.64M	7.78M	2.55M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	70K	70K	71K	13K
Total Long-Term Liabilities	70K	325K	776K	395K
Total Liabilities	3.9M	17.96M	8.56M	2.94M
Total Debt	417K	675K	1.09M	574K
Common Stock	3K	3K	2K	2K
Retained Earnings	-233.05M	-163.42M	-87.9M	-36.39M
Comprehensive Income	105K	237K	-466K	-59K
Shareholders Equity	76.43M	109.46M	126.74M	172.42M
Total Investments	44.87M	98.95M	106.82M	113.18M